Dependent variable | Independent variable | Device model | P value | Effect size |
Bias | Ref. spO2 | AM801 | 0.014 | −0.111 (−0.198 to −0.023) |
MD300C19 | <0.001 | −0.255 (−0.355 to −0.156) | ||
PC-60F | <0.001 | −0.210 (−0.571 to 0.152) | ||
FP likelihood | Ref. spO2 | AM801 | <0.001 | 0.369 (0.210 to 0.650) |
CMS50D | <0.001 | 0.616 (0.485 to 0.783) | ||
PC-60F | 0.043 | 0.666 (0.449 to 0.987) | ||
FN likelihood | Ref. spO2 | AM801 | 0.045 | 22.05 (1.068 to 455.1) |
Bias | FSP score | MD300C19 | 0.020 | −0.428 (−0.788 to −0.068) |
MD300C29 | 0.001 | −0.886 (−1.412 to −0.360) | ||
Bias | PAD status | MD300C29 | 0.011 | −2.010 (−3.456 to −0.474) |
PC-60F | 0.028 | 1.143 (0.126 to 2.160) | ||
Bias | Smoking status | MD300C19 | 0.018 | 1.451 (0.255 to 2.646) |
The p value and coefficient is reported for each significant effect. 95% CIs are shown in parentheses after the effect size values. Where the dependent variable is bias effect size is given by the multiple regression coefficient, where is is FN or FP likelihood effect size is given by the OR.
FN, false negative; FP, false positive; FSP, Fitzpatrick Skin Pigmentation; PAD, peripheral arterial disease; spO2, oxygen saturation.